Randomized trial of Bacillus Calmette-Guérin (percutaneous administration) as surgical adjuvant immunotherapy for patients with stage-II melanoma

Ann N Y Acad Sci. 1976;277(00):187-94. doi: 10.1111/j.1749-6632.1976.tb41697.x.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • BCG Vaccine / administration & dosage
  • BCG Vaccine / adverse effects
  • BCG Vaccine / therapeutic use*
  • Dinitrochlorobenzene / immunology
  • Female
  • Humans
  • Immunotherapy
  • Injections
  • Male
  • Melanoma / immunology
  • Melanoma / surgery
  • Melanoma / therapy*
  • Middle Aged

Substances

  • BCG Vaccine
  • Dinitrochlorobenzene